Dr. Peter Attia
speaker
5,258 appearances
36 recordings
6 series
first heard Jan 2024
last heard Jun 2025
Dr. Peter Attia’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsNo recordings in the last 12 months.Older appearances are listed below; set an alert to hear about the next one.
Appearances
What was the pharma landscape like in the early 90s? So you had Bristol-Myers, you had Pfizer, you had Merck.
How long did it take them to thank your husband for forcing them to bring you along?
When you pause at where we are in this story to think of everything that would come from this moment forward and to realize there's a scenario under which nobody knows everything that's about to happen, and you're an oncologist in Kentucky right now.
1976.
Okay. Give folks a little bit of a history of Genentech. Genentech's a storied company, but also a different company in that it was founded on a new technology.
Tell people briefly how this worked. What was recombinant DNA technology? What were they putting the gene into? How did they get the gene to make the protein? We take this all for granted today because we have... It's tricky, yeah. Yeah, but it's so incredible.
Do you have a sense of how many kids that was?
By this point, it was being used rampantly in sports.
Was it being used by this point also pretty heavily in HIV, right?
Meaning there was no benefit to an HIV patient being on growth hormone?
Did they go after that knowing what they were doing? Or was this a bit of a fishing expedition where they realized in the process of trying to do many things that, oh my God, we can actually make TPA, which you're going to explain in a minute why that changed the game of cardiovascular medicine.
Was Eric at Scripps at that time or where was he?
You had to make sure it wasn't hemorrhagic or you could make things so much worse.
Why did they out-license insulin?
Got it.
And why did you decide to leave? Bristol-Myers Squibb is just crushing it. You finally earned the respect you deserve. You've got this struggling company, Genentech. Was it the opportunity?
So what was the first thing you worked on?
Who developed EPO? Amgen. Amgen, okay.
Got it.
When you clone it, if you publish it, that doesn't give you the right, it's a race for everybody.
Showing 761–780 of 5,258 · page 39 of 263
← Previous
Next →